Risk Profile and 1-Year Outcome of Newly Diagnosed Atrial Fibrillation in Japan - Insights From GARFIELD-AF -


Creative Commons License

Koretsune Y., Etoh T., Katsuda Y., Suetsugu T., Kumeda K., Sakuma I., ...More

CIRCULATION JOURNAL, vol.83, no.1, pp.67-97, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 83 Issue: 1
  • Publication Date: 2019
  • Doi Number: 10.1253/circj.cj-18-0655
  • Journal Name: CIRCULATION JOURNAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.67-97
  • Keywords: GARFIELD-AF, Non-valvular atrial fibrillation, Oral anticoagulation, STROKE, WARFARIN, REGISTRY, THERAPY
  • Dokuz Eylül University Affiliated: No

Abstract

Background: Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective non-interventional study of stroke prevention in patients with newly diagnosed non-valvular AF (NAVF) that is being conducted in 35 countries.